Hodgkin Disease Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Tissue Collection for Studies of Lymph Cancer
Recruiting
  • Hodgkin Disease
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Biospecimen Procurement for Genitourinary Malignancies Branch Immunotherapy Protocols
    Recruiting
    • Multiple Myeloma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      T
      A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation
      Active, not recruiting
      • Hodgkin Disease
      • Lymphoma, Large-cell, Anaplastic
        • Astrakhan, Russian Federation
        • +49 more
        2022-03-31
        Mar 31, 2022
        N
        Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
        Recruiting
        • Waldenstrom Macroglobulinemia
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2022-03-31
          Mar 31, 2022
          B
          A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
          Active, not recruiting
          • Hodgkin Disease
          • Nivolumab
          • +2 more
          • Birmingham, Alabama
          • +77 more
          2022-03-31
          Mar 31, 2022
          W
          Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
          Enrolling by invitation
          • Breast Neoplasm
          • +5 more
          • AH-HA Tool in the EPIC EHR
          • Fort Smith, Arkansas
          • +7 more
          2022-03-25
          Mar 25, 2022
          S
          A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)
          Recruiting
          • Hodgkin Disease
          • Peripheral T Cell Lymphoma
          • brentuximab vedotin
          • +3 more
          • Birmingham, Alabama
          • +53 more
          2022-03-18
          Mar 18, 2022
          C
          A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
          Recruiting
          • Late Effects
          • +8 more
          • PASCA intervention
          • Lyon, France
            Centre Leon Berard
          2022-03-15
          Mar 15, 2022
          T
          A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin
          Recruiting
          • Hodgkin Disease
          • Lymphoma, T-Cell, Cutaneous
          • No Intervention
          • San Bartolome, Alicante, Spain
          • +29 more
          2022-03-10
          Mar 10, 2022
          W
          Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
          Recruiting
          • Acute Myelogenous Leukemia
          • +4 more
          • Stem cell transplantation
          • +3 more
          • Saint Louis, Missouri
            Washington University School of Medicine
          2022-03-10
          Mar 10, 2022
          M
          Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
          Recruiting
          • Hodgkin Disease
          • +2 more
          • pembrolizumab
          • Favezelimab
          • Gilbert, Arizona
          • +24 more
          2022-03-07
          Mar 7, 2022
          W
          Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
          Recruiting
          • Lung Cancer
          • +8 more
          • Home-based cardiac rehabilitation
          • Saint Louis, Missouri
            Washington University School of Medicine
          2022-03-04
          Mar 4, 2022
          U
          Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
          Active, not recruiting
          • Hodgkin Disease
          • +8 more
          • ATLCAR.CD30 cells
          • Chapel Hill, North Carolina
          • +1 more
          2022-03-02
          Mar 2, 2022
          W
          Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies
          Active, not recruiting
          Has Results
          • Acute Myelogenous Leukemia
          • +10 more
          • Atlanta, Georgia
          • +2 more
          2022-02-09
          Feb 9, 2022
          B
          A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
          Not yet recruiting
          • Lymphoma, Non-Hodgkin
          • Hodgkin Disease
          • Orlando, Florida
          • +19 more
          2022-02-15
          Feb 15, 2022
          U
          Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
          Recruiting
          • Multiple Myeloma
          • +11 more
          • Pre-biotic foods/drinks
          • Charlottesville, Virginia
            University of Virginia
          2022-02-14
          Feb 14, 2022
          B
          Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
          Recruiting
          • Hodgkin Lymphoma
          • +2 more
          • Antigen-Escalation Stage
          • +3 more
          • Houston, Texas
          • +1 more
          2022-02-04
          Feb 4, 2022
          S
          Safety Study of SEA-CD40 in Cancer Patients
          Active, not recruiting
          • Carcinoma, Non-Small-Cell Lung
          • +19 more
          • Intravenous (IV) SEA-CD40
          • +4 more
          • Birmingham, Alabama
          • +18 more
          2022-02-01
          Feb 1, 2022
          B
          Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A
          Active, not recruiting
          • Hodgkin Disease
          • Houston, Texas
            Texas Children's Hospital
          2022-01-19
          Jan 19, 2022
          M
          Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
          Recruiting
          • Multiple Myeloma
          • +2 more
          • Acupuncture
          • +2 more
          • New York, New York
          • +1 more
          2022-01-12
          Jan 12, 2022
          U
          Fitness Assessment in Young Adults Recovered From Lymphoma
          Not yet recruiting
          • Young Adults
          • +2 more
          • Indirect calorimetric test during submaximal exercise
          • Clermont-Ferrand, France
            CHU de Clermont-Ferrand
          2021-12-27
          Dec 27, 2021
          B
          Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
          Recruiting
          • Hodgkin Disease
          • +5 more
          • MABEL CTLs
          • +2 more
          • Houston, Texas
          • +1 more
          2022-01-05
          Jan 5, 2022
          T
          Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE - 2021
          Completed
          • Hodgkin Disease
          • Brentuximab Vedotin
          • +3 more
          • Bruxelles, Belgium
          • +18 more
          2021-12-06
          Dec 6, 2021
          B
          Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)
          Active, not recruiting
          Has Results
          • Hodgkin Disease
          • Los Angeles, California
          • +37 more
          2021-10-25
          Oct 25, 2021
          T
          A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma - 2021
          Completed
          Has Results
          • Hodgkin Disease
          • Brentuximab vedotin
          • +3 more
          • Aurora, Colorado
          • +13 more
          2021-10-01
          Oct 1, 2021